Department of Pharmacy, Banasthali Vidhyapith, Banasthali, Rajasthan, India.
Pharm Dev Technol. 2013 May-Jun;18(3):560-9. doi: 10.3109/10837450.2011.604782. Epub 2011 Aug 26.
Enteric submicron particles (SPs) formulations of α-amylase were prepared by w/o/w emulsion solvent evaporation using hydroxypropyl methylcellulose phthalate (HPMCP) and Eudragit L 100, to avoid gastric inactivation of α-amylase. Smaller internal and external aqueous phase volume provided maximum encapsulation efficiency (71.92-73.40%), least particle size (546.4-595.4 nm) and 23-26% loss of enzyme activity. Release studies in 0.1 N HCl confirmed the gastro-resistance of formulations. The anionic SPs aggregated in 0.1 N HCl (i.e. gastric pH 1.2), due to protonation of carboxylic groups of enteric polymer. The aggregates being < 500 µm size would not impede gastric emptying. However, at pH >5.0 (duodenal pH), SPs showed de-aggregation due to restoration of surface charge. HPMCP and Eudragit L 100 SPs facilitated almost complete release of α-amylase within 30 min at pH 6.0 and 6.8, respectively, following Higuchi kinetics. PXRD and DSC indicated amorphous character and scanning electron microscope showed spherical shape of SPs. In simulated gastro-intestinal pH condition, HPMCP and Eudragit L 100 SPs showed good digestion of cooked rice and could serve as potential carrier for oral enzyme delivery. Stability studies indicated the formulations as quite stable to ensure 2 years shelf life at room temperature.
采用 w/o/w 乳液溶剂蒸发法,使用羟丙甲纤维素邻苯二甲酸酯(HPMCP)和 Eudragit L 100 制备α-淀粉酶的肠溶性亚微米颗粒(SPs)制剂,以避免α-淀粉酶在胃中失活。较小的内水相和外水相体积提供了最大的包封效率(71.92-73.40%)、最小的粒径(546.4-595.4nm)和 23-26%的酶活损失。在 0.1N HCl 中的释放研究证实了制剂的胃耐受力。由于肠溶性聚合物的羧基质子化,阴离子 SPs 在 0.1N HCl(即胃 pH 值 1.2)中聚集。聚集物的粒径<500 µm 不会阻碍胃排空。然而,在 pH>5.0(十二指肠 pH 值)时,SPs 由于表面电荷的恢复而发生解聚集。HPMCP 和 Eudragit L 100 SPs 分别在 pH 值为 6.0 和 6.8 时,按照 Higuchi 动力学,在 30 分钟内几乎完全释放了α-淀粉酶。PXRD 和 DSC 表明 SPs 具有无定形特征,扫描电子显微镜显示 SPs 呈球形。在模拟的胃肠 pH 条件下,HPMCP 和 Eudragit L 100 SPs 对煮熟的米饭具有良好的消化作用,可作为口服酶传递的潜在载体。稳定性研究表明,该制剂在室温下相当稳定,可确保 2 年的货架期。